Evidence map›Paper›PMID 34767442›Full record

ArticleScience advances2021

The Human Proteoform Project: Defining the human proteome.

Lloyd M Smith, Jeffrey N Agar, Julia Chamot-Rooke, Paul O Danis, Ying Ge, Joseph A Loo, Ljiljana Paša-Tolić, Yury O Tsybin, Neil L Kelleher, Consortium for Top-Down Proteomics

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 230 citations in OpenAlex.

  1. Article
  2. A Draft Map of E. coli Proteoforms.Analytical chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Lloyd M SmithDepartment of Chemistry, University of Wisconsin, Madison, WI, USA.ORCID 0000-0002-6652-8639
Jeffrey N AgarDepartments of Chemistry and Chemical Biology and Pharmaceutical Sciences, Northeastern University, Boston, MA, USA.ORCID 0000-0003-2645-1873
Julia Chamot-RookeDepartment of Structural Biology and Chemistry, Institut Pasteur, CNRS, Paris, France.ORCID 0000-0002-9427-543X
Paul O DanisConsortium for Top-Down Proteomics, Cambridge, MA, USA.ORCID 0000-0002-4592-9572
Ying GeDepartment of Cell and Regenerative Biology, Department of Chemistry, Human Proteomics Program, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-5211-6812
Joseph A LooDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, USA.ORCID 0000-0001-9989-1437
Ljiljana Paša-TolićPacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0001-9853-5457
Yury O TsybinSpectroswiss, Lausanne, Switzerland.ORCID 0000-0001-7533-0774
Neil L KelleherDepartments of Chemistry, Molecular Biosciences and the Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.ORCID 0000-0002-8815-3372
Consortium for Top-Down Proteomics
University of Wisconsin–Madison · USCentre National de la Recherche Scientifique · FRNortheastern University · USNorthwestern University · USPacific Northwest National Laboratory · USSpectroswiss (Switzerland) · CHUniversity of California, Los Angeles · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
Revealing Proteoforms: The Primary Effectors of Biological FunctionR35GM126914 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Lloyd M Smith · 2018 to 2026
$6.2M
Top Down Proteomics Of Myofilaments In Heart FailureR01HL096971 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GE, YING · 2011 to 2021
$3.3M
UV Laser for Photodissociation-Mass Spectrometry of Proteins and Protein ComplexesR01GM103479 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A · 2012 to 2021
$3.2M
Enabling Top-Down Proteomics through Materials Chemistry and NanotechnologyR01GM117058 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI GE, YING, JIN, SONG · 2015 to 2023
$2.7M
MASH Explorer, a Comprehensive Software Environment for Top-Down ProteomicsR01GM125085 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI GE, YING · 2018 to 2021
$1.2M
NCATS NIH HHS UL1 TR001422NHLBI NIH HHS R01 HL096971NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R01 GM103479NIGMS NIH HHS R01 GM117058NIGMS NIH HHS R01 GM125085NIGMS NIH HHS R35 GM126914
6 · The paper itself

Abstract

Proteins are the primary effectors of function in biology, and thus, complete knowledge of their structure and properties is fundamental to deciphering function in basic and translational research. The chemical diversity of proteins is expressed in their many proteoforms, which result from combinations of genetic polymorphisms, RNA splice variants, and posttranslational modifications. This knowledge is foundational for the biological complexes and networks that control biology yet remains largely unknown. We propose here an ambitious initiative to define the human proteome, that is, to generate a definitive reference set of the proteoforms produced from the genome. Several examples of the power and importance of proteoform-level knowledge in disease-based research are presented along with a call for improved technologies in a two-pronged strategy to the Human Proteoform Project.

Identifiers

PMID34767442
PMCPMC8589312
OpenAlexW3212853007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.